Swiss Takeover Board rejects requests

Press release

Swiss Takeover Board rejects requests

Tel Aviv / Zurich, December 20, 2018 - SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) ("SHL"), a leading provider and developer of advanced personal telemedicine solutions announced today that the Swiss Takeover Board ("TOB") has issued the following order dated 18 December 2018 on the requests dated 30 November 2018 of Himalaya (Cayman Islands) TMT Fund, Himalaya Asset Management Ltd., Xiang Xu and Kun Shen as well and Mengke Cai as well as a request dated 5 December 2018 of Mengke Cai. The requests dated 30 November 2018 relate to an extension of the deadline to launch a mandatory tender offer which expired on 31 August 2018. The request dated 5 December 2018 relates to a removal of the suspension of voting rights:

1. The requests of Himalaya (Cayman Islands) TMT Fund, Himalaya Asset Management Ltd., Xiang Xu and Kun Shen as well as of Mengke Cai dated 30 November 2018 and the request of Mengke Cai of 5 December 2018 are not to be treated.
   
2. The requests of Himalaya (Cayman Islands) TMT Fund, Himalaya Asset Management Ltd., Xiang Xu and Kun Shen as well as of Mengke Cai dated 30 November 2018 and the request of Mengke Cai of 5 December 2018 shall be transferred to the Federal Administrative Court, along with the files of the procedure.
   
3. All other requests are rejected.
   
4. SHL Telemedicine Ltd. shall publish the order of this decision by 20 December 2018 at the latest.
   
5. Following the publication by SHL Telemedicine Ltd. according to para. 4, this decision shall be published on the website of the Takeover Board.
   
6. The fees jointly and severally charged to Himalaya (Cayman Islands) TMT Fund, Himalaya Asset Management Ltd., Xiang Xu, Kun Shen and Mengke Cai amount to CHF20,000.

Appeal (art. 140 of the Financial Market Infrastructure Act, SR 958.1):

This order is subject to an appeal with the Swiss Financial Market Supervisory Authority FINMA, Laupenstrasse 27, CH-3003 Bern within a period of five trading days. The appeal must be made in writing and must be substantiated. The appeal has to suffice the requirements of art. 52 of the Federal Act on Administrative Procedure.

For further information please contact:

Martin Meier-Pfister, IRF Communications, Phone: [phone], [e-mail]

About SHL Telemedicine

SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957). For more information, please visit the web site at www.shl-telemedicine.com.

Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to publicly update or revise any forward-looking statements.

Press release (PDF)

Provider		Channel		Contact
EQS Group Ltd., Switzerland switzerland.eqs.com		newsbox.ch www.newsbox.ch		Provider/Channel related enquiries [e-mail] [phone]